Front-line treatment of inoperable or metastatic pancreatic cancer with gemcitabine and capecitabine: an intergroup, multicenter, phase II study-Reference-Cited by-同舟云学术

Front-line treatment of inoperable or metastatic pancreatic cancer with gemcitabine and capecitabine: an intergroup, multicenter, phase II study

Published:2004-02 Issue:2 Volume:15 Page:224-229
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Stathopoulos G.P.,Syrigos K.,Polyzos A.,Fountzilas G.,Rigatos S.K.,Ziras N.,Potamiannou A.,Tsiakopoulos I.,Androulakis N.,Aravantinos G.,Athanasiadis A.,Papakotoulas P.,Georgoulias V.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/15/2/224/364011/mdh065.pdf

Reference25 articles.

1. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial;Burris;J Clin Oncol,1997

2. Phase II trial of gemcitabine (2.2 difluorodeoxycytidine) in patients with adenocarcinoma of the pancreas;Casper;Invest New Drugs,1994

3. Chemotherapy of adenocarcinoma of the pancreas;Schnall;Semin Oncol,1996

4. Phase I–II study of Gemcitabine and Fluorouracil as a continuous infusion in patients with pancreatic cancer;Hidalgo;J Clin Oncol,1999

5. Phase II trial of CPT-11 in patients with advanced pancreatic cancer. An EORTC Early Clinical Trials Group study;Wagener;Ann Oncol,1995

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of gemcitabine and capecitabine combination for patients with previously treated advanced primary pulmonary lymphoepithelioma-like carcinoma: a retrospective single-arm cohort study;Translational Lung Cancer Research;2023-01

2. Two decades of research toward the treatment of locally advanced and metastatic pancreatic cancer: Remarkable effort and limited gain;Seminars in Oncology;2021-02

3. Chemotherapy for Advanced Pancreatic Cancer: Available Drugs, Mechanisms and Toxicity;Textbook of Pancreatic Cancer;2021

4. Development and In Vitro Evaluation of Long Circulating Liposomes for Targeted Delivery of Gemcitabine and Irinotecan in Pancreatic Ductal Adenocarcinoma;AAPS PharmSciTech;2020-08

5. Efficacy and safety of gemcitabine plus capecitabine in the treatment of advanced or metastatic pancreatic cancer: a systematic review and meta-analysis;Annals of Palliative Medicine;2020-07